Growth Metrics

Palvella Therapeutics (PVLA) Enterprise Value Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -246.25%
Dec 31, 2025 30.65%
Sep 30, 2025 -347.43%
Jun 30, 2025 -384.51%
Mar 31, 2025 -1,110.40%
Dec 31, 2024 -412.27%
Sep 30, 2024 74.95%
Jun 30, 2024 77.58%
Mar 31, 2024 87.09%
Dec 31, 2023 72.42%
Sep 30, 2023 18.77%
Jun 30, 2023 19.89%
Mar 31, 2023 51.75%
Dec 31, 2022 49.76%
Sep 30, 2022 -100.07%
Jun 30, 2022 11.83%
Mar 31, 2022 -50.02%
Dec 31, 2021 -67.19%
Sep 30, 2021 57.77%
Jun 30, 2021 -18.89%
Mar 31, 2021 22.97%
Dec 31, 2020 32.37%
Sep 30, 2020 4.18%
Jun 30, 2020 22.54%
Mar 31, 2020 21.68%
Dec 31, 2019 16.80%
Sep 30, 2019 37.19%
Jun 30, 2019 33.97%
Mar 31, 2019 30.58%
Dec 31, 2018 -72.36%
Sep 30, 2018 -52.69%
Jun 30, 2018 -200.01%
Mar 31, 2018 -188.88%
Dec 31, 2017 -147.41%
Sep 30, 2017 -145.97%
Jun 30, 2017 -24.64%
Mar 31, 2017 -77.12%
Dec 31, 2016 -0.02%
Sep 30, 2016 -13.34%
Jun 30, 2016 -302.64%
Mar 31, 2016 -136.87%
Dec 31, 2015 -58.87%
Sep 30, 2015 -3,345.36%
Jun 30, 2015 -575.24%
Mar 31, 2015 -302.68%
Dec 31, 2014 -400.74%
Sep 30, 2014 -135,973.11%
Jun 30, 2014 -28,457.81%